#Clinical trials

2 stories

Industry April 9, 2026 · View digest

Global Obesity Pipeline Surges Past 80 Pharma Companies in Active Clinical Trials

Over 80 pharmaceutical companies are running clinical trials in obesity. Boehringer Ingelheim is advancing survodutide into three global Phase III trials, positioning it as a key next-generation GLP-1 competitor.

Regulatory April 2, 2026 · View digest

STAT News: FDA Peptide Compounding Shift and Iran Conflict Impact on Clinical Trials

STAT's pharmaceutical roundup covers the FDA's expected move to allow compounding of previously banned peptides and the impact of the Iran conflict on global clinical trial recruitment.